[{"Assets_0_FY_USD":737988000.0,"CommonStockSharesOutstanding_0_FY_shares":74142619.0,"EarningsPerShareBasic_4_FY_USD":-2.57,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-147180000.0,"NetIncomeLoss_4_FY_USD":-187091000.0,"NetIncomeLossConverted_4_FY_USD":-187091000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":29390000.0,"StockholdersEquity_0_FY_USD":602568000.0,"Ticker":"RVMD","CIK":"1628171","name":"REVOLUTION MEDICINES, INC.","OfficialName":"Revolution Medicines Inc. Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1775342076.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20220228"}]